UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway

Experimental biology and medicine (Maywood, N.J.), 2015-12, Vol.240 (12), p.1690-1697

2015

Volltextzugriff (PDF)

1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro

Journal of the American Society of Nephrology, 2000-10, Vol.11 (10), p.1857

2000

Volltextzugriff (PDF)

1,25-Dihydroxycholecalciferol and macrophage differentiation with aging

Experimental gerontology, 1990, Vol.25 (3), p.233-238

1990

Volltextzugriff (PDF)

1,25-Dihydroxycholecalciferol and Parathormone: Effects on Isolated Osteoclast-Like and Osteoblast-Like Cells

Science (American Association for the Advancement of Science), 1977-08, Vol.197 (4304), p.663-665

1977

Volltextzugriff (PDF)

1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone

Endocrinology (Philadelphia), 1981-06, Vol.108 (6), p.2293-2301

1981

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors

Biochemical and biophysical research communications, 1999-10, Vol.264 (2), p.590-595

1999

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs

Endocrinology (Philadelphia), 1986-09, Vol.119 (3), p.1298-1304

1986

Volltextzugriff (PDF)

1,25‐Dihydroxyvitamin D protects against age‐related osteoporosis by a novel VDR‐Ezh2‐p16 signal axis

Aging cell, 2020-02, Vol.19 (2), p.e13095-n/a

2020

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D sub(3) causes an increase in the number of osteoclastlike cells in cat bone marrow cultures

Calcified tissue international, 1985-01, Vol.37 (3), p.276-281

1985

Volltextzugriff (PDF)

1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast‐supporting stromal cells

Journal of cellular biochemistry, 1999-09, Vol.74 (4), p.587-595

1999

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line

Endocrinology (Philadelphia), 1993-02, Vol.132 (2), p.862-866

1993

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 causes an increase in the number of osteoclastlike cells in cat bone marrow cultures

Calcified tissue international, 1985-05, Vol.37 (3), p.276-281

1985

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow

Proceedings of the National Academy of Sciences - PNAS, 1985-12, Vol.82 (23), p.8213-8217

1985

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 effects on human cultured osteoclast-like multinucleated cells

Nippon Seikeigekagakkai zasshi, 1994-04, Vol.68 (4), p.162

Nishi, T

1994

Volltextzugriff (PDF)

1,25‐Dihydroxyvitamin D3 Hypersensitivity of Osteoclast Precursors from Patients with Paget's Disease

Journal of bone and mineral research, 2000-02, Vol.15 (2), p.228-236

2000

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression

Joint, bone, spine : revue du rhumatisme, 2013-05, Vol.80 (3), p.307-314

2013

Volltextzugriff (PDF)

1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss

Calcified tissue international, 1990-09, Vol.47 (3), p.152-157

1990

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry

Endocrinology (Philadelphia), 1987-02, Vol.120 (2), p.531-536

1987

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 /Parathormone Affect Fetal Osteoclastic Bone Resorption In Vivo

Hormone and metabolic research, 1985-09, Vol.17 (9), p.483-484

1985

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption

The Journal of clinical investigation, 1987-08, Vol.80 (2), p.425-429

1987

Volltextzugriff (PDF)

1,25-Dihydroxyvitamin D3 transcriptionally activates the beta 3-integrin subunit gene in avian osteoclast precursors

Endocrinology (Philadelphia), 1994-03, Vol.134 (3), p.1061-1066

1994

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3Causes Formation of Multinucleated Cells with Several Osteoclast Characteristics in Cultures of Primate Marrow

Proceedings of the National Academy of Sciences - PNAS, 1985-12, Vol.82 (23), p.8213-8217

1985

Volltextzugriff (PDF)

1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells

Experimental cell research, 2017-09, Vol.358 (2), p.260-268

2017

Volltextzugriff (PDF)

1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts

The Journal of immunology (1950), 2002-09, Vol.169 (5), p.2374-2380

2002

Volltextzugriff (PDF)

1,25(OH)2D3 and calcipotriol (MC903) have similar effects on the induction of osteoclast-like cell formation in human bone marrow cultures

Biochemical and biophysical research communications, 1990-09, Vol.171 (3), p.1056-1063

1990

Volltextzugriff (PDF)

1 – 25 von 26.601

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23.179)
Mit Volltextzugriff
(22.518)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(20.789)
Connected Ingenta
(12.629)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(12.545)
Journals@Ovid
(8.234)
Access via Wiley Online Library
(5.151)
Access via ScienceDirect (Elsevier)
(5.013)
Single Journals
(4.597)
IngentaConnect Journals
(4.502)
Wiley Online Library Full Collection 2018
(4.418)
EZB-NALI5-00465 Elsevier Archive NL
(4.298)
SpringerNature Journals
(3.037)
EZB-NALI2-00462 Springer Archive NL
(2.296)
Access via Oxford University Press
(1.931)
Nature
(971)
Access via Taylor & Francis
(648)
Oxford Journals 2020 Medicine
(620)
Taylor & Francis Current Content Access
(550)
Access via Taylor & Francis
(513)
Access via SAGE
(485)
JSTOR Archive Collection A-Z Listing
(417)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(145)
... seit 30 Tagen
(35)

Menü

Weitere Dienste

Einstellungen

The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway

1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro

1,25-Dihydroxycholecalciferol and macrophage differentiation with aging

1,25-Dihydroxycholecalciferol and Parathormone: Effects on Isolated Osteoclast-Like and Osteoblast-Like Cells

1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone

1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors

1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs

1,25‐Dihydroxyvitamin D protects against age‐related osteoporosis by a novel VDR‐Ezh2‐p16 signal axis

1,25-Dihydroxyvitamin D sub(3) causes an increase in the number of osteoclastlike cells in cat bone marrow cultures

1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast‐supporting stromal cells

1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line

1,25-Dihydroxyvitamin D3 causes an increase in the number of osteoclastlike cells in cat bone marrow cultures

1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow

1,25-Dihydroxyvitamin D3 effects on human cultured osteoclast-like multinucleated cells

1,25‐Dihydroxyvitamin D3 Hypersensitivity of Osteoclast Precursors from Patients with Paget's Disease

1,25-dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression

1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss

1,25-dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry

1,25-Dihydroxyvitamin D3 /Parathormone Affect Fetal Osteoclastic Bone Resorption In Vivo

1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption

1,25-Dihydroxyvitamin D3 transcriptionally activates the beta 3-integrin subunit gene in avian osteoclast precursors

1,25-dihydroxyvitamin D3Causes Formation of Multinucleated Cells with Several Osteoclast Characteristics in Cultures of Primate Marrow

1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells

1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts

1,25(OH)2D3 and calcipotriol (MC903) have similar effects on the induction of osteoclast-like cell formation in human bone marrow cultures

Suchergebnisse filtern